What is ALS Phase 2 Study KNS-760704?

Category: Others

false

R(+) pramipexole dihydrochloride monohydrate [R(+)PPX], an experimental neuroprotective drug, is provided in this open label extension study to ALS patients who have participated in earlier clinical protocols.

Why patients stopped taking ALS Phase 2 Study KNS-760704

Multiple reasons could be selected

Reason Patients
Course of treatment ended 1
See 1 patient who's stopped using ALS Phase 2 Study KNS-760704

Duration

Stopped using ALS Phase 2 Study KNS-760704

Duration Patients
6 months - 1 year 1
Last updated:
There are no evaluations for ALS Phase 2 Study KNS-760704.